Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
filingDate |
1994-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_136b20816207b77996ae11ec8f67ea04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb65713e5426353ada9ed800a03700b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5516ad49b0b0a74e4b2bd568c153adf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9ef5e1130623f41d912d9f53fe576c |
publicationDate |
1995-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H0797393-A |
titleOfInvention |
Novel endothelin antagonist peptide |
abstract |
(57) [Summary] [Structure] Structural formula [Chemical formula 1] And a related compound thereof and uses thereof. [Effect] Since the compound represented by the structural formula [I] and its analogs have a strong antagonistic action on the endogenous bioactive peptide endothelin via the ET B receptor, endothelin It is useful as a therapeutic agent for various pathological conditions involved. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008024720-A |
priorityDate |
1993-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |